GreenLight Biosciences

0.30
0.00 (0.13%)
At close: Jul 21, 2023, 8:00 PM

Company Description

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications.

Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops.

The company was founded in 2008 and is headquartered in Medford, Massachusetts.

GreenLight Biosciences
GreenLight Biosciences logo
Country United States
IPO Date Feb 3, 2022
Industry Biotechnology
Sector Healthcare
Employees 280
CEO Dr. Andrey Juan Zarur Ph.D.

Contact Details

Address:
200 Boston Avenue
Medford, Massachusetts
United States
Website https://greenlightbiosciences.com

Stock Details

Ticker Symbol GRNA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001822691
CUSIP Number 39536G105
ISIN Number US39536G1058
Employer ID 85-1914700
SIC Code 2836

Key Executives

Name Position
Dr. Andrey Juan Zarur Ph.D. Co-Founder, Pres, Chief Executive Officer & Director
Carole Beth Cobb M.B.A. Chief Operating Officer
Charu Manocha M.B.A. Chief People Officer
Dr. Drew Cunningham Ph.D. Chief Technology Officer
Susan E. Keefe M.B.A. Chief Financial Officer & Interim Chief Accounting Officer
David D. Kennedy Esq. Advisor
Dr. Amin Khan Ph.D. Chief Science Officer of Human Health
Dr. Mark T. Singleton Ph.D. Chief Commercial Officer & Gen. Mang. of Plant Health
Dr. Shelly Karuna Chief Medical Officer
Nina C. Thayer Gen. Counsel
Thomas Crampton Senior Vice President & Head of Corporation Affairs

Latest SEC Filings

Date Type Title
Aug 11, 2023 15-12G Filing
Jul 28, 2023 SC 13D/A [Amend] Filing
Jul 28, 2023 SC 13D/A [Amend] Filing
Jul 28, 2023 8-K/A [Amend] Current Report
Jul 27, 2023 SC 13D/A [Amend] Filing
Jul 27, 2023 4 Filing
Jul 27, 2023 3 Filing
Jul 27, 2023 4 Filing
Jul 27, 2023 4 Filing
Jul 27, 2023 4 Filing